Washington University School of Medicine: Prostatic Neoplasms trials

The registry lists 22 Prostatic Neoplasms studies with Washington University School of Medicine as lead sponsor. 9 are open to participants now and 3 have results posted.

Phase 1 4Phase 2 4No phase 15(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Sipuleucel-T (Sip-T) in Combination With N-803 in Metastatic Androgen Pathway Modulation Resistant (mAPMR) Prostate CancerNot yet recruitingNCT07756593Phase 1
• [18F]Fluorthanatrace - Positron Emission Tomography (FTT-PET) and ctDNA to Predict Response to PARP Inhibitor Therapy in Metastatic Prostate Cancer (mPC)Not yet recruitingNCT07723651Phase 2
• Prostate Specific Membrane Antigen (PSMA) Imaging for Detection of Residual and Metastatic Prostate CancerNot yet recruitingNCT07593079Phase 2
• CARE Tool Study Aim 3RecruitingNCT07296887Not applicable
• Low-Count Quantitative SPECT for Men Treated With Radium-223RecruitingNCT07221825Not applicable
• Impact of an Electronic Health Record Maintenance Alert on PSA Screening Rates in a 10-Hospital Integrated Health SystemRecruitingNCT07109427Not applicable
• Diffusion Basis Spectrum Imaging of the ProstateRecruitingNCT04420702Not applicable
• Circulating Tumor DNA (ctDNA) for Early Treatment Response Assessment of Solid TumorsRecruitingNCT04354064
• Safety and Efficacy of 21 Gy, 23 Gy and 25 Gy for High Dose Rate (HDR) Prostate BrachytherapyRecruitingNCT03424850Phase 1/2
• Adaptive Stereotactic Body Radiation Therapy to the Prostate and Pelvic Nodes With Simultaneous Integrated Boost to the MR-detected Nodule for Patients With High-risk and Unfavorable Intermediate-risk Prostate CancerActive, not recruitingNCT05628363Not applicableResults posted
• Ibrutinib as Neoadjuvant Therapy in Localized Prostate CancerCompletedNCT02643667Phase 2Results posted
• Feasibility Study of Prostate Tumor Localization for Focal Cryoablation of Prostate CarcinomaTerminatedNCT00851682Not applicableResults posted
• Enhanced Assistance During Radiotherapy for Unmet Essential NeedsCompletedNCT06582849Not applicable
• Neoadjuvant SGLT2 Inhibition in Localized Prostate CancerTerminatedNCT04887935Phase 1
• Cost Talk: Discussing Cancer Care CostsCompletedNCT04397016Not applicable
• Neoantigen DNA Vaccine in Combination With Nivolumab/Ipilimumab and PROSTVAC in Metastatic Hormone-Sensitive Prostate CancerCompletedNCT03532217Phase 1
• Physical Activity Intervention in African American Men After Radical ProstatectomyWithdrawnNCT02621684Not applicable
• Detecting Recurrent Prostate Cancer With C-11 Choline Positron Emission Tomography: An Expanded Access StudyApproved for marketingNCT02355054
• Does Protein Restriction Inhibit Prostrate Cancer GrowthCompletedNCT01692587Not applicable
• Prostate Cancer Prospective CohortActive, not recruitingNCT00937586
• A Pilot Study of Physical Activity for Improving Quality of Life in Prostate Cancer Patients on Androgen Deprivation Therapy (ADT)CompletedNCT00853164Not applicable
• Positron Emission Tomography in Prostate CancerCompletedNCT00121212Not applicable